Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT02788773 · COMPLETED
Trial details
- NCT number
- NCT02788773
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-15
- Primary completion
- 2021-11-22
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.